Latest Press Release: 26th July 2018
Cambridge, UK – 26th July, 2018 – Healx (https://healx.io), the Cambridge (UK) technology company developing breakthrough treatments for rare diseases, today announced a $10 million Series A funding round, led by Balderton Capital, Europe's leading early-stage venture investor. Existing investors, Jonathan Milner and Amadeus Capital Partners also participated in the round.
Press Release: 4th October 2016
Machine learning and advanced analytics help Healx identify new uses for existing drugs London, UK – 4 Oct 2016 – Amadeus Capital Partners, the global technology investor, has made an early-stage investment in Healx , an innovative British healthcare company that seeks new uses for existing drugs in the fight against rare diseases. Amadeus [...]